MSI-H/ MMRd
Who we are
Autologous CD8+ and CD4+ Transgenic T Cells Expressing High Affinity KRASG12V Mutation-Specific T Cell Receptors (FH-A11KRASG12V-TCR) in Treating Patients With Metastatic Pancreatic, Colorectal and Non-Small Cell Lung Cancers With KRAS G12V Mutations
Envafolimab Combined With Trifluridine/Tipiracil and Bevacizumab in the Treatment of Refractory mCRC.
A Study of ELI-002 7P in Subjects With KRAS/NRAS Mutated Solid Tumors
Phase I Trial of Adagrasib (MRTX849) in Combination With Cetuximab and Irinotecan in Patients With Colorectal Cancer
Fc-Engineered Anti-CTLA-4 Monoclonal Antibody Botensilimab in Advanced Cancer
Evaluation for NCI Surgery Branch Immunotherapy Clinical Research Protocols
Neo-T in Treating Patients With Advanced Solid Tumors(GI-NeoT-03)
Personalized TCR-T: Study of Adoptively Transferred T-cell Receptor Gene-engineered T Cells (TCR-T)
Evaluating Novel Therapies in ctDNA Positive GI Cancers
Disitamab Vedotin Combined With Tislelizumab in Advanced HER2 Positive Colorectal Cancer
